Two cancer researchers from Switzerland and Germany honored
Keystone-SDA
Tobias Weiss and Juliane Walz, cancer researchers from Switzerland and Germany respectively, have been honoured with the 2024 Swiss Bridge Award. Each will receive CHF250,000 ($288,000) to support their work in cancer treatment using immunotherapies.
+ Get the most important news from Switzerland in your inbox
This year’s Swiss Bridge Foundation cancer research prize focuses on supporting early-stage clinical trials, the foundation announced on Tuesday. These initial studies aim to test new drugs or therapies on patients with incurable cancer for the first time. In total, 36 young researchers from across Europe applied for the prize.
More
More
Swiss cancer research could ‘boost’ immunotherapy
This content was published on
Feb 4, 2023
Swiss researchers have made major advances in cancer immunotherapy but bringing these to patients faces challenges.
Read more: Swiss cancer research could ‘boost’ immunotherapy
Tobias Weiss from the University Hospital Zurich has been researching a treatment for glioblastoma, the most common and aggressive form of brain tumour in adults. Weiss and his team extract immune cells from the patient’s blood and modify them to recognise and attack tumour cells, according to Swiss Bridge.
The second prize winner is Juliane Walz from the University of Tübingen in Germany. She and her team have been researching a bispecific antibody designed to bind specifically to two different proteins on different cell types, the report stated. They hope this dual action will effectively combat tumours.
Translated from German by DeepL/sp
How we work
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Articles in this story